Literature DB >> 22535529

Three case reports of inherited antithrombin deficiency in China: double novel missense mutations, a nonsense mutation and a frameshift mutation.

Haoyu Deng1, Wei Shen, Yi Gu, Xiong Ma, Jiwei Zhang, Lan Zhang.   

Abstract

Antithrombin is a plasma protein critical to the regulation of coagulation. It plays a pivotal anticoagulant role by preventing the activation of procoagulant proteinases. Inherited and (or) acquired deficiency of AT is an established risk factor for venous thromboembolism. Sequencing analysis of SERPINC1 gene of three families revealed that Family I had double novel missense mutations (c.134G > A&c.342T > G), Family II had a nonsense mutation (c.770G > A) while Family III had a frameshift mutation (c.800-803del). In addition, all of them had a large number of carriers in their families what was very rare in China.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535529     DOI: 10.1007/s11239-012-0733-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  16 in total

1.  Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction.

Authors:  Byung-Boong Lee; Leonel Villavicencio; Young Wook Kim; Young Soo Do; Kwang Chul Koh; Hyo Keun Lim; Jae Hoon Lim; Keung Whan Ahn
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

2.  Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.

Authors:  Weiqing Zhang; Richard Swanson; Yan Xiong; Benjamin Richard; Steven T Olson
Journal:  J Biol Chem       Date:  2006-10-13       Impact factor: 5.157

Review 3.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

4.  Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells.

Authors:  Weiqing Zhang; Yung-Jen Chuang; Tianquan Jin; Richard Swanson; Yan Xiong; Lawrence Leung; Steven T Olson
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

5.  Novel mutation (E113X) of antithrombin III gene (AT3) in a woman with gestational recurrent thrombosis.

Authors:  H Yamada; N Hoshi; E H Kato; Y Ebina; T Kishida; T Sagawa; K Matsuno; S Fujimoto
Journal:  Am J Med Genet       Date:  2000-04-24

Review 6.  Antithrombin: in control of coagulation.

Authors:  Noelene S Quinsey; Ainslie L Greedy; Stephen P Bottomley; James C Whisstock; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2004-03       Impact factor: 5.085

Review 7.  Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion.

Authors:  K Okuda; M Kage; S M Shrestha
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

8.  Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells.

Authors:  Weiqing Zhang; Yung-Jen Chuang; Richard Swanson; Juan Li; Kyunga Seo; Lawrence Leung; Lester F Lau; Steven T Olson
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

Review 9.  Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.

Authors:  Peter S Maclean; R Campbell Tait
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Shape-shifting serpins--advantages of a mobile mechanism.

Authors:  James A Huntington
Journal:  Trends Biochem Sci       Date:  2006-07-03       Impact factor: 13.807

View more
  2 in total

1.  Rare double heterozygous mutations in antithrombin underlie hereditary thrombophilia in a Chinese family.

Authors:  Haoyu Deng; Jiaquan Chen; Hui Xie; Yi Gu; Kai Yuan; Peng Wang; Wei Shen; Wei Liang; Hao Zhang; Jiwei Zhang; Jun Xie; Lan Zhang
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

2.  Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.

Authors:  Teena Bhakuni; Amit Sharma; Qudsia Rashid; Charu Kapil; Renu Saxena; Manoranjan Mahapatra; Mohamad Aman Jairajpuri
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.